Cargando…
An emerging potential of metabolomics in multiple sclerosis: a comprehensive overview
Multiple sclerosis (MS) is an inflammatory demyelinating disease of the nervous system that primarily affects young adults. Although the exact etiology of the disease remains obscure, it is clear that alterations in the metabolome contribute to this process. As such, defining a reliable and disease-...
Autores principales: | Zahoor, Insha, Rui, Bin, Khan, Junaid, Datta, Indrani, Giri, Shailendra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8038957/ https://www.ncbi.nlm.nih.gov/pubmed/33449145 http://dx.doi.org/10.1007/s00018-020-03733-2 |
Ejemplares similares
-
Blood-based untargeted metabolomics in relapsing-remitting multiple sclerosis revealed the testable therapeutic target
por: Zahoor, Insha, et al.
Publicado: (2022) -
A metabolomic approach to identifying platinum resistance in ovarian cancer
por: Poisson, Laila M, et al.
Publicado: (2015) -
Current and Future Biomarkers in Multiple Sclerosis
por: Yang, Jennifer, et al.
Publicado: (2022) -
Multiple sclerosis in India: An overview
por: Singhal, Bhim S., et al.
Publicado: (2015) -
An Overview of Peptide-Based Molecules as Potential Drug Candidates for Multiple Sclerosis
por: Del Gatto, Annarita, et al.
Publicado: (2021)